Cargando...
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer mortality in the United States and the second leading cause of cancer mortality worldwide. Sorafenib is the only food and drug administration (FDA) approved as first line systemic treatment in HCC. Regorafenib and nivolumab are the...
Guardado en:
| Publicado en: | World J Gastrointest Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952267/ https://ncbi.nlm.nih.gov/pubmed/29770170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v10.i5.108 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|